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Abstract
Background: The passive leg-raising (PLR) maneuver provides a dynamic assessment of fluid responsiveness
inducing a reversible increase in cardiac preload. Since its effects are sudden and transitory, a continuous cardiac
output (CO) monitoring is required to appropriately assess the hemodynamic response of PLR. On the other hand,
changes in partial end-tidal CO2 pressure (PETCO2) have been demonstrated to be tightly correlated with changes
in CO during constant ventilation and stable tissue CO2 production (VCO2). In this study we tested the hypothesis
that, assuming a constant VCO2 and under fixed ventilation, PETCO2 can track changes in CO induced by PLR and
can be used to predict fluid responsiveness.
Methods: Thirty-seven mechanically ventilated patients with acute circulatory failure were monitored with the
CardioQ-ODM esophageal Doppler. A 2-minutes PLR maneuver was performed. Fluid responsiveness was defined
according to CO increase (responders ≥ 15%) after volume expansion.
Results: PLR-induced increases in CO and PETCO2 were strongly correlated (R
2 = 0.79; P < 0.0001). The areas under
the receiver-operating characteristics (ROC) curve for a PLR-induced increase in CO and PETCO2 (0.97 ± 0.03 SE; CI
95%: 0.85 to 0.99 and 0.94 ± 0.04 SE; CI 95%: 0.82 to 0.99; respectively) were not significantly different. An increase
≥ 5% in PETCO2 or ≥ 12% in CO during PLR predicted fluid responsiveness with a sensitivity of 90.5% (95% CI: 69.9
to 98.8%) and 95.2% (95% CI: 76.2 to 99.9%), respectively, and a specificity of 93.7% (95% CI: 69.8 to 99.8%).
Conclusion: Induced changes in PETCO2 during a PLR maneuver could be used to track changes in CO for
prediction of fluid responsiveness in mechanically ventilated patients with acute circulatory failure, under fixed
minute ventilation and assuming a constant tissue CO2 production.
Keywords: Fluid responsiveness, Passive leg raising, Cardiac output, Preload, Esophageal Doppler, Partial end-tidal
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Background
The passive leg-raising (PLR) maneuver provides a
dynamic assessment of preload dependence inducing a
transient and reversible increase in cardiac preload. The
abrupt transfer of blood contained in the venous reser-
voir of the legs and splanchnic compartment while mov-
ing the patient from a semirecumbent to supine position
with legs elevated increases cardiac preload as a ‘self-
volume challenge’ and, when both ventricles are operat-
ing in the steep part of the Frank-Starling curve, also
improves cardiac output (CO) [1]. This maneuver has
been demonstrated to predict fluid responsiveness in
many studies over a wide population, including clinical
situations in which other parameters of fluid responsive-
ness have failed, such as patients with cardiac arrhyth-
mias or with spontaneous breathing [1-3]. However,
since the hemodynamic effects of PLR are usually sud-
den and transient, a fast-response continuous CO moni-
tor is required to detect these changes and to
characterize fluid responder patients accurately [4-6]. In
* Correspondence: ignaciomonge@gmail.com
Unidad de Investigación Experimental. Servicio de Cuidados Críticos y
Urgencias. Hospital SAS de Jerez, Jerez de la Frontera, C/Circunvalación s/n,
11407 Jerez de la Frontera, Spain
Monge García et al. Annals of Intensive Care 2012, 2:9
http://www.annalsofintensivecare.com/content/2/1/9
© 2012 Monge García et al; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.this regard, several monitoring techniques have been
proposed for this purpose: echocardiography [2,3,7],
arterial pulse contour analysis [8,9], bioreactance [10],
esophageal Doppler [1,11,12], and so on. Nevertheless,
the need for measuring CO usually limits the wide-
spread application of this test to a specific group of
patients requiring expensive, burdensome or invasive
hemodynamic monitoring systems.
The relationship between CO and partial end-tidal
CO2 pressure (PETCO2) has been known for decades
[13,14], so measurement of PETCO2 has been proposed
to confirm the restoration of spontaneous circulation in
patients with cardiac arrest [15], but also as a quantita-
tive indicator of hemodynamic effectiveness of precor-
dial compression during cardiopulmonary resuscitation
[16]. Moreover, since PETCO2 is mainly determined by
tissue CO2 production (VCO2), alveolar ventilation and
CO (that is, pulmonary blood flow) [17], when stable
metabolic conditions are assumed and minute ventila-
tion is kept constant, acute changes in PETCO2 have
been shown to correlate strongly with changes in CO in
experimental [18-24] and clinical [25,26] settings. Thus,
PETCO2 has been suggested as a noninvasive alternative
for continuous assessment of CO in different shock
states [20].
The aim of the present study, therefore, was to assess
whether PETCO2 monitoring can track changes in CO
induced by PLR and can be used as a noninvasive surro-
gate for predicting fluid responsiveness in mechanically
ventilated patients with acute circulatory failure requir-
ing fluid administration.
Methods
This study was prospectively conducted in a 17-bed
adult multidisciplinary Intensive Care Unit of the Hospi-
tal del SAS Jerez de la Frontera. The study protocol was
approved by the Institutional Ethics Committee of the
Hospital Jerez of the Andalusian Health Service and
endorsed by the Scientific Committee of the Spanish
Society of Intensive Care, Critical and Coronary Units
(SEMICYUC). Written informed consent was obtained
from each patient’s next of kin.
Patients
Inclusion criteria were patients with controlled mechani-
cal ventilation and for whom the attending physician
decided to give fluids due to the presence of at least one
of the following signs of circulatory failure: systolic
blood pressure ≤ 90 mmHg or a decrease ≥ 50 mmHg
in a previously hypertensive patient; the need of vaso-
pressor drugs; urine output ≤ 0.5 ml/kg/hr during at
least two hours; heart rate > 100 beats/minute; and pre-
sence of skin mottling or delayed capillary refilling.
Exclusion criteria were age < 18 years, pregnancy, any
contraindication for the use of esophageal Doppler
(recent esophageal surgery, malformation, varicose or
tumor) or to perform PLR (intracranial hypertension,
deep venous thrombosis, the use of venous elastic com-
pression stockings, or limb and pelvic fractures).
To avoid changes in alveolar ventilation, patients were
ventilated in volume control mode and spontaneous
respiratory movements were temporally suppressed with
a neuromuscular blockade agent (0.1 mg/kg vecuronium
bromide) if detected in airway pressure trace in the
respiratory monitor.
Measurements
Respiratory measurements
PETCO2 was continuously measured at the tip of the
endotracheal tube using a sidestream infrared gas analy-
zer (compact airway module M-COVX, Datex-Ohmeda,
Helsinki, Finland) integrated into the patient monitor
(S/5, Datex-Ohmeda, Helsinki, Finland) and recorded
online in a laptop computer every 10 seconds using pro-
prietary data acquisition software (S/5 Collect software,
version 4.0; Datex-Ohmeda, Helsinki, Finland). The vali-
dation of this compact modular metabolic monitor for
use in mechanically ventilated patients in the ICU has
been published elsewhere [27]. The precision of the gas
analyzer module for PETCO2 measurements was calcu-
lated as twice its coefficient of variation (CV = SD/
mean), determined in all studied patients at baseline
during stable hemodynamic and respiratory conditions.
The least significant change (LSC) was calculated as the
precision × √2, which sets the minimum percentage
change between successive measurements that can be
considered not due to random error and therefore
representing a real change in PETCO2 [28]. Since as the
random error increases, larger effects are necessary to
detect a real change, responsiveness of the gas analyzer
for PETCO2 measurements was also calculated, which
refers to the ability to detect a change over time, provid-
ing an estimation of the ‘sensitivity to change’ of a mea-
surement tool [29]. We calculated the Guyatt’s
Responsiveness Index (GRI) as GRI = LSC divided by
the standard deviation of the PLR-induced changes in
PETCO2.AG R Iv a l u e≥ 0.8 is considered a high
responsiveness [30].
Hemodynamic measurements
Hemodynamic monitoring was performed using the
CardioQ-ODM™ esophageal Doppler monitor (Deltex
Medical, Chicester, UK). This device allows minimally
invasive real-time CO monitoring by measuring aortic
blood flow velocity at the descending thoracic aorta,
assuming a constant aortic diameter (obtained from a
nomogram based on the patient’s age, weight and
height) and that a constant proportion of the CO flows
through the descending aorta [31]. This monitor also
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the corrected flow time (FTc), which is adjusted to the
heart rate using Bazett’s formula (FTc = the systolic
blood flow time divided by the square root of the cycle
time) and has been proposed as a gross estimation of
the loading condition of the heart [32]; and the mean
acceleration (Acc), which represents the mean accelera-
tion of the aortic blood flow and has been suggested as
an indicator of the left ventricular systolic function [33].
The Doppler probe was inserted into the esophagus via
the nasal route and advanced until it achieved the maxi-
mal aortic blood flow velocity signal. The gain setting
was then adjusted to obtain the optimum outline of the
aortic velocity waveform. Hemodynamic parameters
were continuously recorded every 10 seconds for further
offline analysis.
All Doppler measurements were performed by the
same observer (MIMG). The intraobserver reproducibil-
ity for CO measurements was determined using the
Bland-Altman test analysis in ten randomly selected
patients over a one-minute period and described as bias
± limits of agreements (1.96SD), and presented as per-
centages and absolute values (in brackets). We also cal-
culated precision and LSC for Doppler CO
measurements at pre-infusion and post-infusion stages.
Since Doppler parameters were averaged during one
minute before and after fluid administration, precision
was determined by the coefficient of error (CE = CV/
√N, where N = 6 is the number of measurements) and
LSC as 2√2 × CE [28].
Study protocol
The study protocol was performed in four sequential
stages (Figure 1). A first set of measurements was
recorded with the patient in the semirecumbent position
(baseline). Next the PLR maneuver was performed by
setting the patient in the supine position and simulta-
n e o u s l yr a i s i n gt h ep a t i e n t ’s leg to 45° to maximize the
hemodynamic effect of the test (PLR) [9]. The patient
was then returned to the semirecumbent position and,
after five minutes, a new set of measurements was
obtained before (pre-infusion) and immediately after
fluid administration (post-infusion), which consisted of
500 ml of a synthetic colloid (Voluven 6% hydroxyethyl
starch solution 130/0.4; Fresenius Kabi, Bad Homburg,
Germany) administered over 30 minutes. The hemody-
namic and PETCO2 measurements during each protocol
period were expressed as an average of the measure-
ments collected during one minute, except for the PLR
stage, in which they were recorded at the moment at
which they reached their maximum values [1].
Supportive therapies, ventilatory settings and vasopres-
sor therapy were kept unchanged throughout the study
period.
Statistical analysis
Normal distribution of data was tested using the
D’Agostino-Pearson test. All variables except PETCO2
were normally distributed. The results are expressed as
means ± SD or as median and the interquartile range
(IQR), as appropriate. Sample size was calculated for
detection of differences of 0.10 with known expected
area under the ROC curve [34]. We selected a type I
e r r o ro f0 . 0 5a n dat y p eI Ie r r o ro f0 . 2 ,a s s u m i n gt h a t
fluid responsiveness occurs in 50% of ICU patients [35].
Patients were classified according to CO increase after
fluid administration as responders (≥ 15%) and non-
responders, respectively [1,11]. To validate this cutoff
we determined that every responder patient increased
CO above the individual LSC value [28]. Differences
between responders and non-responders were compared
by means of an independent sample t-test for hemody-
namic parameters and by the Mann-Whitney U test for
PETCO2 measurements. The effects of fluid administra-
tion on hemodynamic parameters were assessed using a
paired Student’s t-test and by Wilcoxon rank sum test
for PETCO2 measurements. The relationships between
variables were analyzed using a linear regression
method. The ability of PETCO2 to track directional
changes in CO (trending capability) during PLR and
fluid administration was tested using a concordance
analysis. Concordance was defined as the percentage of
data in which the direction of change was in agreement
[36]. The area under the ROC curves for PLR-induced
changes in CO (ΔCOPLR) and PETCO2 (ΔPETCO2-PLR),
and pre-infusion FTc according to volume expansion
(VE) response were calculated and compared using the
Hanley-McNeil test. ROC curves are presented as area ±
SE (95% confidence interval). A P value < 0.05 was con-
sidered statistically significant. All statistical analyses
were two-tailed and were performed using MedCalc
software for Windows version 11.6.1.0 (MedCalc Soft-
ware bvba, Mariakerke, Belgium).
Results
Patients’ characteristics
From January to May 2011, 37 consecutive patients were
included. Two patients were excluded because of
Figure 1 Study protocol.
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characteristics are summarized in Table 1, including 21
fluid responders (57%) and 16 non-responders. All the
patients had sinus rhythm, although transient supraven-
tricular extrasystoles were observed during the study in
some patients (13%).
The intraobserver variability for esophageal Doppler
CO measurements was 0.6 ± 4.9% (-0.02 ± 0.21 L/min).
At pre-infusion, the precision and mean LSC for Dop-
pler CO measurements were 2.3% (IQR: 1.7 to 3%; 95%
CI: 1.8 to 2.7%) and 3.2% (IQR: 2.4 to 4.2%; 95% IC: 2.5
to 3.8%), respectively; at post-infusion, these values were
1.9% (IQR: 1.3 to 3.9%; 95% CI: 1.5 to 2.6%) and 2.6%
(IQR: 1.8 to 5.4%; 95% IC: 2.1 to 3.6%). For PETCO2
measurements, the precision and mean LSC were 1.3%
(IQR: 1.04 to 1.7%; 95% CI: 1.09 to 1.57%) and 1.84%
(IQR: 1.47 to 2.41%; 95% CI: 1.54 to 2.22%), respectively.
The responsiveness of the gas analyzer according to
Guyatt’sR e s p o n s i v e n e s sI n d e xw a s1 . 5 8( I Q R :1 . 2 6t o
2.07; 95% IC: 1.32 to 1.91).
Effects of passive leg-raising maneuver
Overall, the PLR maneuver increased CO by 15.9 ± 9.1%
(95% CI: 12.9 to 18.9%; P < 0.0001), stroke volume (SV)
by 15.5 ± 10.2% (95% CI: 12.1 to 18.9%; P < 0.0001), FTc
by 8.4 ± 6% (95% CI: 6.4 to 10.4%; P < 0.0001), mean
arterial pressure (MAP) by 5.4% (IQR: 1.3 to 10.2%; 95%
CI: 1.8 to 7.6%; P < 0.0001), arterial pulse pressure (PP)
by 10.1% (IQR: 2.3 to 21.8; P < 0.0001), and PETCO2 by
5.32 ± 3.09% (95% CI: 4.29 to 6.35%; P < 0.0001). Neither
heart rate nor Acc changed during PLR.
In fluid-responder patients, ΔPETCO2-PLR was 7.34 ±
2.26% (95% CI: 6.32 to 8.37%) with an absolute increase
of 2.54 ± 0.99 mmHg (95% CI: 2.09 to 2.99 mmHg),
whereas in non-responders, this value was 2.66 ± 1.69%
(95% CI: 1.76 to 3.56%), with an absolute increase of
0.92 ± 0.61 mmHg (95% CI: 0.59 to 1.24 mmHg). All
volume responders showed a ΔPETCO2-PLR greater than
their individual baseline LSCs.
The CO increase during PLR strongly correlated with
ΔPETCO2-PLR (R
2 =0 . 7 9 ;P < 0.0001) but was weaker
with PLR-induced changes in arterial PP (R
2 =0 . 2 9 ;P <
0.001) (Figure 2). The directional changes between
ΔPETCO2-PLR and CO induced by PLR displayed a 97%
concordance.
After the PLR maneuver, at the pre-infusion period, all
the parameters returned to similar baseline values.
Effects of volume expansion
In the entire study population, VE increased CO by 18.9
± 17.1% (95% CI: 13.1 to 24.6%; P < 0.0001), SV by
17.4% (IQR: 6.1 to 31.2%; 95% CI: 9.3 to 22.3; P <
0.0001); FTc by 8.4 ± 8.7% (95% CI: 5.5 to 11.3%; P <
0.0001), MAP by 4.7% (IQR: 1.2 to 13.4%; 95% CI: 2.3
to 10.6%; P = 0.0001); arterial PP by 12.5% (IQR: 1.6 to
25.9; P < 0.001); and PETCO2 by 1.69 ± 3.55% (95% CI:
0.51 to 2.88% mmHg; P < 0.01). All the VE-responder
patients exhibited an increase in CO after VE greater
than their individual LSC values for Doppler CO
measurements.
The VE-induced increase in CO was correlated with
changes in PETCO2, PP and FTc after fluid administration
(R
2 = 0.56, R
2 =0 . 4 5a n dR
2 = 0.7, respectively; P <0 . 0 0 0 1 ) .
Changes between VE-induced increases in PETCO2 and
Table 1 Characteristics and demographic data of study
population
Age (years) 64 ± 13
Gender (M/F) 16/21
Weight (kg) 77 ± 17.2
Height (cm) 166.9 ± 7.6
Body surface area (m
2) 1.88 ± 0.21
Body mass index (Kg m
-2) 25.9 (23.4 to 31.2)
APACHE II score at admission 18.8 ± 7.3
ICU survival rate (%) 24 (65%)
Plasma lactate level, mmol/L 2.79 ± 1.82
Ventilator settings
Tidal volume, mL/Kg predicted body weight 8.1 ± 1.2
Respiratory rate, b.p.m. 20 (18 to 20)
Total PEEP, cm H2O 6.4 (4 to 8)
Mean airway pressure, cmH2O 12 (9.4 to 13)
Peak airway pressure, cmH2O 31.1 ± 6.2
FiO2,% 0.73 ± 0.2
Vasoactive agents, n; dose (μgk g
-1 min
-1)
Norepinephrine 22; 0.23 (0.08 to 0.33)
Dobutamine 6; 6.2 (3.3 to 9.5)
Analgesia and sedative drugs
Fentanyl, n; dose (μgk g
-1 h
-1) 24; 1.58 ± 0.53
Remifentanyl, n; dose (μgk g
-1 min
-1) 13; 0.14 ± 0.04
Midazolam, n; dose (mg kg
-1 h
-1) 24; 0.09 ± 0.03
Propofol, n; dose (mg kg
-1 min
-1) 2; 0.79 (0.7 to 0.89)
ARDS, n 3
Days on mechanical ventilation 1( 1t o1 )
ICU length of stay, days 8 (5 to 16)
Reason for fluid administration, n (%)
Hypotension 11 (30%)
Oliguria 30 (81%)
Decrease vasoactive dosage 19 (51%)
Sepsis/Septic shock 26 (70%)
Abdominal 11 (30%)
Pulmonary 10 (27%)
Urological 2 (7%)
Neurological 2 (7%)
Other 1 (3%)
APACHE, Acute Physiologic and Chronic Health Evaluation; ARDS, acute
respiratory distress syndrome; F, female; FiO2, inspired oxygen fraction; ICU,
intensive care unit; M, male; PEEP, positive end-expiratory pressure; SaO2,
arterial oxygen saturation. Values are expressed as mean ± SD, median (25
th
to 75
th percentile) or absolute numbers, as appropriate
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after fluid administration was also correlated with ΔCOPLR
and ΔPETCO2-PLR (R
2 =0 . 7a n dR
2 =0 . 5 5 ,r e s p e c t i v e l y ;P <
0.0001) (Figure 3). So, the greater the changes in CO and
PETCO2 during the PLR maneuver, the greater the
expected increase in CO after VE. No correlation between
pre-infusion FTc values and VE-induced changes in CO
was observed (R
2 = 0.09; P: n.s.).
The hemodynamic and PETCO2 measurement
throughout the four stages are summarized in Table 2.
Prediction of fluid responsiveness
The area under the ROC curve for ΔCOPLR (0.97 ± 0.03;
95% CI: 0.85 to 0.99) and ΔPETCO2-PLR (0.94 ± 0.03;
95% CI: 0.82 to 0.99) was not significantly different but
was higher than for pre-infusion FTc (0.75 ± 0.08; 95%
CI: 0.58 to 0.88; P < 0.01) and baseline PP (0.73 ± 0.09;
95% CI: 0.55 to 0.86; P < 0.01) (Figures 4 and 5). An
absolute increase in PETCO2 value ≥ 2m m H gd u r i n g
PLR was associated with a positive response to fluid
administration in all cases.
The comparison of predictive performance of different
hemodynamic parameters and ΔPETCO2-PLR for detect-
ing fluid responsiveness is given in Table 3.
Discussion
The main finding of this study is that, under fixed min-
ute ventilation and assuming a constant tissue CO2 pro-
duction, acute changes in partial end-tidal CO2 pressure
during the passive leg-raising maneuver are strongly
correlated with changes in cardiac output measured by
an esophageal Doppler and could provide a reliable and
non-invasive method for predicting fluid responsiveness
in mechanically ventilated patients with acute circulatory
failure.
Although intravascular volume therapy remains a key-
stone in the treatment of patients with acute circulatory
failure, the benefits of fluid administration seem to be
defined within relatively narrow boundaries: on the one
hand, excessive fluid therapy appears to be associated
Figure 3 Linear regression analysis of the relationship between
cardiac output changes induced by volume expansion and
PLR-induced changes in cardiac output and PETCO2. CO, cardiac
output; PLR, passive leg raising; VE, volume expansion.
Figure 2 Linear regression analysis of the relationship between
PLR-induced changes in cardiac output and PETCO2. PETCO2,
partial end-tidal CO2 pressure; PLR, passive leg raising.
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the other hand, inadequate fluid resuscitation could
aggravate tissue hypoperfusion and organ dysfunction
[37]. Furthermore, for physiological reasons, the hemo-
dynamic response to a fluid challenge is not easily pre-
dictable, since the expected improvement in CO is only
observed in half the patients [35]. In this regard, the
PLR maneuver has been proposed as a reliable method
for predicting fluid responsiveness, challenging the car-
diovascular system to a reversible and transient increase
in cardiac preload by mobilizing venous blood contained
in the lower limbs and abdominal compartment toward
the intrathoracic vessels. Only if both ventricles are
operating in the steep part of the cardiac function curve
will this increment in preload result in a significant
increase in CO and, therefore, in a similar response
after volume administration [6].
Our results confirm the ability of the PLR maneuver
to detect preload dependence and the strong relation-
ship between changes induced by PLR and VE-induced
Table 2 Effects of passive leg raising maneuver and volume expansion on hemodynamics and partial end-tidal CO2
Baseline PLR Preinfusion After VE
CO, L/min
Responders 5.40 ± 2.25 6.54 ± 2.53
b 5.33 ± 2.43 6.81 ± 2.81
c
Non-responders 6.51 ± 2.47 7.03 ± 2.73
b 6.48 ± 2.52 6.85 ± 2.89
c
SV, mL
Responders 53.5 ± 26.3
a 63.8 ± 26.5
b 52.5 ± 26.9
a 68.1 ± 27.5
c
Non-responders 76.4 ± 31.3 82.7 ± 33.5
b 76.3 ± 30.9 81.5 ± 33.1
c
HR, b.p.m.
Responders 106 ± 25
a 106 ± 24
a 106 ± 26
a 103 ± 24
a
Non-responders 88 ± 20 87 ± 18 87 ± 20 86 ± 19
FTc, ms
Responders 292 ± 51
a 323 ± 50
b 291 ± 52
a 327 ± 54
c
Non-responders 343 ± 61 360 ± 74
b 342 ± 62 355 ± 83
Acc, m/s
2
Responders 9.6 ± 4.5 9.7 ± 4.9 9.3 ± 4.6 10.4 ± 5.4
c
Non-responders 10.3 ± 3.9 10.5 ± 4.1 10.3 ± 3.9 10.7 ± 4.7
SAP, mmHg
Responders 107 ± 21 120 ± 21
b 108 ± 21 122 ± 25
c
Non-responders 107 ± 14 111 ± 16
b 105 ± 15 111 ± 18
c
DAP, mmHg
Responders 61 ± 11 65 ± 12
b 61 ± 12 64 ± 12
c
Non-responders 63 ± 11 66 ± 10
b 63 ± 10 65 ± 10
c
MAP, mmHg
Responders 76 ± 14 83 ± 13
b 75 ± 14 83 ± 15
c
Non-responders 78 ± 12 82 ± 12
b 77 ± 12 81 ± 13
c
PP, mmHg
Responders 45.8 ± 15.7 55.3 ± 18.3
b 46.9 ± 13.6 57.7 ± 19.7
a, c
Non-responders 42.1 ± 10.1 45.2 ± 11.9
b 42.1 ± 11.3 45.9 ± 12.9
c
CPO, W
Responders 0.92 ± 0.44 1.22 ± 0.49
b 0.91 ± 0.47 1.25 ± 0.51
c
Non-responders 1.10 ± 0.38 1.26 ± 0.46
b 1.11 ± 0.43 1.23 ± 0.53
c
TSVR, dyn·s·cm
-5
Responders 1264 ± 442 1143 ± 368
b 1299 ± 481 1130 ± 451
c
Non-responders 1124 ± 535 1091 ± 510 1119 ± 504 1133 ± 538
PETCO2, mmHg
Responders 35 (30 to 37) 38 (33 to 40)
b 35 (29 to 37) 36 (30 to 38)
c
Non-responders 34 (30 to 37) 35 (30 to 38)
b 34 (29 to 37) 34 (28 to 37)
Acc, mean aortic blood flow acceleration; CO, cardiac output; CPO, cardiac power output (mean arterial pressure x cardiac output/451);, DAP, diastolic arterial
pressure; HR, heart rate; FTc, aortic blood flow corrected time; MAP, mean arterial pressure; PETCO2, partial end-tidal CO2 pressure; PP, arterial pulse pressure
(systolic minus diastolic pressure); SAP, systolic arterial pressure; SV, stroke volume; TSVR, total systemic vascular resistance
aP < 0.05 versus non-responders;
bP < 0.05 versus baseline;
cP < 0.05 versus preinfusion. Data are expressed as mean ± SD, except for PETCO2 as median (25
th to
75
th percentiles)
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predicting fluid responsiveness is also consistent with
previous studies in which esophageal Doppler was
employed [1,11] and similar to the recommended
threshold value for interpretation of PLR maneuver
effects [6,34]. Accordingly, when CO increased above
12%, 95% of the studied patients increased their CO
after fluid administration.
Exhaled or end-tidal CO2 is mainly determined by
pulmonary blood flow (that is, CO), metabolic CO2 pro-
duction (VCO2) and alveolar ventilation; so PETCO2
varies directly with VCO2 and CO and inversely with
alveolar ventilation [17]. Therefore, assuming that dur-
ing PLR the systemic metabolic rate remained relatively
constant (and minute ventilation was kept unchanged),
then changes in PETCO2 should predominantly reflect
variations in pulmonary blood flow and thus, indirectly,
changes in CO. The strong relationship observed
between changes in PETCO2 and CO during PLR sup-
ports this hypothesis and it is also in agreement with
numerous studies performed under similar conditions
[18-26]. For this reason, the measurement of PETCO2
has been advocated as a simple and noninvasive para-
meter of the circulatory status for monitoring the
resumption of spontaneous circulation and the efficacy
of chest compressions during cardiac arrest [15] but
also as a prognostic indicator in cardiopulmonary resus-
citation [38] and emergency trauma surgery [39].
According to previous observations [22,25], the
increase in PETCO2 induced by PLR could be explained
at least by two mechanisms. First, if PLR increases
venous return and pulmonary blood flow, then CO2
delivery to the lungs (that is, pulmonary arterial CO2
content) and CO2 removal should be increased. Second,
by increasing pulmonary perfusion pressure, PLR could
recruit previous collapsed pulmonary vessels and reduce
alveolar spaces with high ventilation-to-perfusion
Figure 4 Individual values and box-plot of studied fluid-responsiveness parameter in responders (open circles) and non-responders
(closed circles). ΔCOPLR, cardiac output changes induced by passive leg raising (PLR); ΔPETCO2-PLR = PETCO2 changes induced by PLR; ΔPP-PLR,
arterial pulse pressure changes induced by PLR; FTc: corrected flow time at pre-infusion time.
Figure 5 Comparison of receiver operating characteristics
curves regarding the ability of studied fluid responsiveness
parameters to discriminate responder patients (cardiac output
increase ≥ 15%) and nonresponder patients after volume
expansion. ΔCOPLR, cardiac output changes induced by passive leg
raising (PLR); ΔPETCO2-PLR, PETCO2 changes induced by PLR; ΔPP-PLR,
arterial pulse pressure changes induced by PLR; FTc: corrected flow
time at pre-infusion time.
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enon could be particularly striking in patients with
severely impaired pulmonary perfusion pressure, as seen
in deep hemorrhagic shock [18,19,21,23] or patients
with alveolar overdistension due to high levels of PEEP
[40]. In this latter regard, a recent study by Fougéres et
al. [41] demonstrated that in patients with ARDS who
were ventilated with high levels of PEEP, the PLR man-
euver improved the cardiac index but also was asso-
ciated with a decrease in pulmonary vascular resistance,
which suggested that by increasing central blood
volume, PLR decreased PEEP-induced West zones 1
with subsequent decrease in alveolar dead space. Unfor-
tunately, since we did not measure arterial CO2 pres-
sure, we cannot estimate the relative influence of
changes in dead space during PLR. In any case, accord-
ing to the above explanation, whatever the underlying
mechanism, the increase in PETCO2 is determined ulti-
mately to an effective increase in pulmonary blood flow
and improved efficiency of alveolar CO2 excretion
[22,25].
Although the relationship between CO and PETCO2
was initially described as linear [14,22,24,25], other
authors have suggested that a logarithmic function bet-
ter defines this association [18,20,21]. According to the
latter, in low-flow states (as during cardiac arrest or
severe hemorrhagic shock), for a given change in CO a
larger variation in PETCO2 should be expected
[18,20,21]. This marked reduction in PETCO2 at low
CO values might be attributed not only to limited CO2
elimination, but also to changes in metabolic CO2 pro-
duction during oxygen supply dependency [21-23]. In
contrast, at high CO values, pulmonary blood flow
would not be the limiting factor for PETCO2, and thus,
changes in PETCO2 would not reflect its variations but
mainly the adequacy of alveolar ventilation [18,20].
Although our study was not designed to address this
specific issue, the strong association observed during
PLR between fractional changes in CO and PETCO2
suggests that, under the conditions described by the
study protocol, this relationship remains valid over the
wide range of studied CO values. Furthermore, the
moderate magnitude of transient changes in CO pro-
duced by PLR (in contrast with marked and sustained
decreases induced in some studies [18-21]) and the tim-
ing between PETCO2 a n dC Om e a s u r e m e n t s[ 2 5 ]m a y
also have contributed to the observed findings in our
study. When perturbations in CO were produced over a
brief period of time and PETCO2 measurements were
performed within a relatively short time frame, similar
results have been observed in previous studies [22,25].
Before drawing conclusions from our results, some
considerations should be mentioned. First, the assess-
ment of fluid responsiveness using PETCO2 variations
should potentially share the same limitations as inter-
preting CO changes during PLR, since in this context
the former is in essence just a surrogate for the latter.
Therefore, any condition that could affect the ability of
PLR to predict fluid responsiveness (for example,
intraabdominal hypertensio n )[ 1 2 ]s h o u l da l s ob ec o n -
sidered when analyzing PETCO2 changes. Second, to
prevent fluctuations in minute ventilation, all the
patients were mechanically ventilated in volume control
mode, deeply sedated and fully adapted to the ventilator
with no inspiratory efforts. Consequently, in sponta-
neously breathing patients, the unpredictable variations
in alveolar ventilation could make the analysis of
changes in PETCO2 more difficult. For this reason, this
population was deliberately excluded from the study and
extrapolation of our results to this clinical condition
cannot be recommended. Third, the assessment of
PETCO2 variations is also based in the assumption that
no significant changes in metabolic CO2 production
have been produced while performing the PLR maneu-
ver. If the metabolic rate varies considerably (for exam-
ple, during shivering, fever, and so on), the observed
changes in PETCO2 could not be attributed solely to
modifications in CO and thus the ability of PETCO2
variations to predict fluid responsiveness could be
diminished. However, the maximum hemodynamic
Table 3 Predictive performance for detecting fluid responsiveness
Threshold Sensitivity Specificity PV + PV - LR + LR -
ΔCOPLR 12% 95.2% 93.7% 95.2% 93.7% 15.24 .05
[95% CI] [76.2-99.9%] [69.8-99.8%] [75.5-99.9%] [69.8-99.8%] [13-17.9] [0.003-0.8]
ΔPETCO2-PLR 5% 90.5% 93.7% 95% 88.2% 14.48 .1
[95% CI] [69.6-98.8%] [69.8-99.8%] [75.1-99.9%] [62.6-98.7%] [12-17.5] [0.01-1]
FTc 300 ms 66.7% 81.2% 82.4% 65% 3.56 .41
[95% CI] [43-85.4%] [54.4-96%] [55.6-96.5%] [40.8-84.6%] [2.4-5.2] [0.1-1.3]
ΔPPPLR 11% 66.7% 81.2% 82.4% 65% 3.56 .41
[95% CI] [43-85.4%] [54.4-96%] [55.6-96.5%] [40.8-84.6%] [2.4-5.2] [0.1-1.3]
ΔCOPLR, passive leg raising induced-change in cardiac output; ΔPETCO2-PLR, passive leg raising-induced change in partial end-tidal CO2;, ΔPP-PLR, passive leg
raising-induced change in arterial pulse pressure; FTc, aortic blood flow corrected time; PV+, positive predictive value; PV -, negative predictive value; LR+,
positive likelihood ratio; LR-, negative likelihood ratio
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ute [6], so it is very unlikely that this phenomenon will
occur in such a short period of time. By contrast, since
infusion time was significantly longer, this assumption is
more difficult to sustain and could be one of the reasons
for the weaker relationship between changes in CO and
PETCO2 after fluid administrat i o n .H o w e v e r ,e v e n
under these circumstances, the VE-induced increase in
CO still accounted for more than 50% of the observed
changes in PETCO2. Finally, the 5% cutoff found for
changes in PETCO2 represents an increase of no more
than 2 mmHg, which ap r i o r ic o u l db ea t t r i b u t e dt oa
low signal-to-noise ratio and easily interpreted as a mea-
surement error. Nonetheless, we effectively confirmed
that this value is almost three times the LSC for
PETCO2 measurement, so under the same conditions,
an increase above this threshold should represent an
actual increase in PETCO2 and the presence of fluid
responsiveness. Despite these considerations, PETCO2
measurement could offer an easily available, totally non-
invasive method for the assessment of fluid responsive-
ness with similar performance as measuring CO, but
without the need of any hemodynamic monitoring
device, when similar clinical conditions are present (uni-
form alveolar ventilation and constant VCO2).
Conclusions
In our study we demonstrated that PETCO2 effectively
tracked changes in CO during the PLR maneuver and
predicted fluid responsiveness in patients with acute cir-
culatory failure with fixed minute ventilation, assuming
a constant tissue CO2 production.
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